These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25562196)

  • 1. Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.
    Shen C; Sun Z; Chen D; Su X; Jiang J; Li G; Lin B; Yan J
    OMICS; 2015 Jan; 19(1):1-11. PubMed ID: 25562196
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of the urinary metabolic variations and the application in bladder cancer biomarker discovery.
    Liu X; Cheng X; Liu X; He L; Zhang W; Wang Y; Sun W; Ji Z
    Int J Cancer; 2018 Jul; 143(2):408-418. PubMed ID: 29451296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bladder cancer biomarker discovery using global metabolomic profiling of urine.
    Wittmann BM; Stirdivant SM; Mitchell MW; Wulff JE; McDunn JE; Li Z; Dennis-Barrie A; Neri BP; Milburn MV; Lotan Y; Wolfert RL
    PLoS One; 2014; 9(12):e115870. PubMed ID: 25541698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker.
    Choi S; Shin JH; Lee YR; Joo HK; Song KH; Na YG; Chang SJ; Lim JS; Jeon BH
    Dis Markers; 2016; 2016():7276502. PubMed ID: 27057081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Raman chemometric urinalysis (Rametrix) as a screen for bladder cancer.
    Huttanus HM; Vu T; Guruli G; Tracey A; Carswell W; Said N; Du P; Parkinson BG; Orlando G; Robertson JL; Senger RS
    PLoS One; 2020; 15(8):e0237070. PubMed ID: 32822394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary metabolomic signature of muscle-invasive bladder cancer: A multiplatform approach.
    Jacyna J; Wawrzyniak R; Balayssac S; Gilard V; Malet-Martino M; Sawicka A; Kordalewska M; Nowicki Ł; Kurek E; Bulska E; Patejko M; Markuszewski M; Gutknecht P; Matuszewski M; Siebert J; Kaliszan R; Markuszewski MJ
    Talanta; 2019 Sep; 202():572-579. PubMed ID: 31171223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA9, PCDH17, POU4F2, and ONECUT2 as a Urinary Biomarker Combination for the Detection of Bladder Cancer in Chinese Patients with Hematuria.
    Wu Y; Jiang G; Zhang N; Liu S; Lin X; Perschon C; Zheng SL; Ding Q; Wang X; Na R; Sun J; Xu J
    Eur Urol Focus; 2020 Mar; 6(2):284-291. PubMed ID: 30309818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CCL18 in a multiplex urine-based assay for the detection of bladder cancer.
    Urquidi V; Kim J; Chang M; Dai Y; Rosser CJ; Goodison S
    PLoS One; 2012; 7(5):e37797. PubMed ID: 22629457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Highly sensitive and specific novel biomarkers for the diagnosis of transitional bladder carcinoma.
    Kumar P; Nandi S; Tan TZ; Ler SG; Chia KS; Lim WY; Bütow Z; Vordos D; De la Taille A; Al-Haddawi M; Raida M; Beyer B; Ricci E; Colombel M; Chong TW; Chiong E; Soo R; Park MK; Ha HK; Gunaratne J; Thiery JP
    Oncotarget; 2015 May; 6(15):13539-49. PubMed ID: 25915536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic and prognostic value of bladder cancer-related transcript markers in urine.
    Schmidt J; Propping C; Siow WY; Lohse-Fischer A; Toma M; Baldauf-Twelker A; Hakenberg OW; Wirth MP; Fuessel S
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):401-14. PubMed ID: 26328914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of early and late stages of bladder cancer using metabolites and machine learning.
    Kouznetsova VL; Kim E; Romm EL; Zhu A; Tsigelny IF
    Metabolomics; 2019 Jun; 15(7):94. PubMed ID: 31222577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine CXCL1 as a biomarker for tumor detection and outcome prediction in bladder cancer.
    Nakashima M; Matsui Y; Kobayashi T; Saito R; Hatahira S; Kawakami K; Nakamura E; Nishiyama H; Ogawa O
    Cancer Biomark; 2015; 15(4):357-64. PubMed ID: 26406865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor, carbonic anhydrase 9, and angiogenin as urinary biomarkers for bladder cancer detection.
    Urquidi V; Goodison S; Kim J; Chang M; Dai Y; Rosser CJ
    Urology; 2012 May; 79(5):1185.e1-6. PubMed ID: 22386755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer.
    Chen X; Zhang J; Ruan W; Huang M; Wang C; Wang H; Jiang Z; Wang S; Liu Z; Liu C; Tan W; Yang J; Chen J; Chen Z; Li X; Zhang X; Xu P; Chen L; Xie R; Zhou Q; Xu S; Irwin DL; Fan JB; Huang J; Lin T
    J Clin Invest; 2020 Dec; 130(12):6278-6289. PubMed ID: 32817589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multi-analyte assay for the non-invasive detection of bladder cancer.
    Goodison S; Chang M; Dai Y; Urquidi V; Rosser CJ
    PLoS One; 2012; 7(10):e47469. PubMed ID: 23094052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of urine fibronectin as a non-invasive diagnostic biomarker in bladder cancer patients: a systematic review and meta-analysis.
    Dong F; Shen Y; Xu T; Wang X; Gao F; Zhong S; Chen S; Shen Z
    World J Surg Oncol; 2018 Mar; 16(1):61. PubMed ID: 29562940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and validation of the methylated TWIST1 and NID2 genes through real-time methylation-specific polymerase chain reaction assays for the noninvasive detection of primary bladder cancer in urine samples.
    Renard I; Joniau S; van Cleynenbreugel B; Collette C; Naômé C; Vlassenbroeck I; Nicolas H; de Leval J; Straub J; Van Criekinge W; Hamida W; Hellel M; Thomas A; de Leval L; Bierau K; Waltregny D
    Eur Urol; 2010 Jul; 58(1):96-104. PubMed ID: 19674832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.